Literature DB >> 6378606

65Zinc and endogenous zinc content and distribution in islets in relationship to insulin content.

D P Figlewicz, S E Forhan, A T Hodgson, G M Grodsky.   

Abstract

Uptake of 65Zn and distribution of 65Zn, total zinc, and insulin were measured in rat islets and islet granules under different conditions of islet culture. Specific activity of islet zinc (65Zn/zinc) was less than 15% that of extracellular zinc even after 48 h. In contrast, once in the islet, 65Zn approached 70% of equilibrium with granular zinc in 24 h and apparent equilibrium by 48 h. During a 24-h culture, at either high or low glucose, reduction of both islet zinc and insulin occurred. However, zinc depletion was greater than that predicted if zinc loss was proportional to insulin depletion and occurred only from the granular compartment, which represents only one third of the total islet zinc. Extension of culture to 48 h caused additional insulin depletion, but islet zinc was unchanged. Omission of calcium during the 48-h culture caused a predicted increase in insulin retention, presumably by inhibiting secretion; however, zinc retention was not increased proportionately. Pretreatment of rats with tolbutamide caused a massive depletion of insulin stored in isolated islets, with little change in total islet zinc; subsequent culture of these islets resulted in a greater loss of granular zinc than predicted from the small loss of granular insulin. None of the conditions tested affected the percentage of either 65Zn or total zinc that was distributed in the islet granules. Results show that zinc exists in a metabolically labile islet compartment(s) as well as in secretory granules; and extra-granular zinc, although not directly associated with insulin storage, may act as a reservoir for granular zinc and may regulate insulin synthesis, storage, and secretion in ways as yet unknown.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378606     DOI: 10.1210/endo-115-3-877

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Acute cytokine-mediated downregulation of the zinc transporter ZnT8 alters pancreatic beta-cell function.

Authors:  Malek El Muayed; Liana K Billings; Meera R Raja; Xiaomin Zhang; Paul J Park; Marsha V Newman; Dixon B Kaufman; Thomas V O'Halloran; William L Lowe
Journal:  J Endocrinol       Date:  2010-05-27       Impact factor: 4.286

Review 2.  Zinc transporter 8 (ZnT8) and β cell function.

Authors:  Howard W Davidson; Janet M Wenzlau; Richard M O'Brien
Journal:  Trends Endocrinol Metab       Date:  2014-04-18       Impact factor: 12.015

Review 3.  The pancreatic β-cell transcriptome and integrated-omics.

Authors:  David M Blodgett; Anthony J Cura; David M Harlan
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-04       Impact factor: 3.243

4.  Potential positive and negative consequences of ZnT8 inhibition.

Authors:  Kristen E Syring; Karin J Bosma; Slavina B Goleva; Kritika Singh; James K Oeser; Christopher A Lopez; Eric P Skaar; Owen P McGuinness; Lea K Davis; David R Powell; Richard M O'Brien
Journal:  J Endocrinol       Date:  2020-08       Impact factor: 4.286

5.  Serum zinc level and dietary zinc intake status in non-alcoholic fatty liver disease: A meta-analysis and systematic review.

Authors:  Sevginur Akdas; Nuray Yazihan
Journal:  Hepatol Forum       Date:  2020-05-21

6.  Accumulation of cadmium in insulin-producing β cells.

Authors:  Malek El Muayed; Meera R Raja; Xiaomin Zhang; Keith W MacRenaris; Surabhi Bhatt; Xiaojuan Chen; Margrit Urbanek; Thomas V O'Halloran; William L Lowe
Journal:  Islets       Date:  2012-11-01       Impact factor: 2.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.